US Tariffs on Drugs Spark Price Hike Fears and Supply Worries
A sudden 100% US tariff on key branded drugs has raised alarms about higher prices and supply chain disruptions, drawing pushback at home and abroad.
PharmaNews
Read More
Novo Nordisk Cheers China’s Healthcare Initiatives
Novo Nordisk, a top diabetes care firm, praises the Chinese mainland’s healthcare efforts, expressing confidence in its market and future plans for patient care.